12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Loading...
Loading...

Gainers

  • SenesTech SNES stock moved upwards by 68.2% to $2.59 during Wednesday's pre-market session. The market value of their outstanding shares is at $5.3 million.
  • TransCode Therapeutics RNAZ shares increased by 30.97% to $0.43. The company's market cap stands at $6.8 million. The company's, Q4 earnings came out 3 days ago.
  • 180 Life Sciences ATNF shares increased by 27.52% to $2.27. The market value of their outstanding shares is at $8.4 million.
  • Immunic IMUX shares rose 21.91% to $1.78. The company's market cap stands at $79.0 million.
  • Biodexa Pharmaceuticals BDRX shares moved upwards by 18.02% to $0.33. The market value of their outstanding shares is at $1.0 million.
  • Viracta Therapeutics VIRX shares moved upwards by 11.47% to $1.65. The market value of their outstanding shares is at $63.3 million.

Losers

  • Assure Hldgs IONM stock declined by 14.9% to $3.15 during Wednesday's pre-market session. The company's market cap stands at $3.4 million. As per the news, the Q4 earnings report came out 2 days ago.
  • Celularity CELU shares decreased by 14.23% to $0.63. The market value of their outstanding shares is at $103.9 million.
  • Pear Therapeutics PEAR shares fell 11.04% to $0.26. The company's market cap stands at $36.8 million.
  • First Wave BioPharma FWBI stock fell 10.41% to $2.41. The company's market cap stands at $3.7 million.
  • Protagonist Therapeutics PTGX shares fell 9.52% to $19.5. The company's market cap stands at $999.8 million.
  • Adamis Pharmaceuticals ADMP shares declined by 7.94% to $0.1. The company's market cap stands at $16.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...